99Tcm-MDP and 99Tcm-DPD in pathologic bone lesions. A visual and quantitative comparison

Area of Science:

• Nuclear Medicine
• Radiopharmacology
• Oncology Imaging

Background:

• Bone scintigraphy is crucial for detecting bone metastases.
• 99Tcm-methylene diphosphonate (MDP) and 99Tcm-dicarboxypropane diphosphonate (DPD) are commonly used bone-seeking radiopharmaceuticals.
• Evaluating the comparative efficacy of MDP and DPD is important for optimizing diagnostic accuracy.

Purpose of the Study:

• To compare the diagnostic efficiency of 99Tcm-MDP and 99Tcm-DPD in detecting pathological bone uptake.
• To assess quantitative and visual differences in lesion detection between MDP and DPD.

Main Methods:

• Quantitative intra-individual comparison of lesion-to-normal bone ratios in 12 patients with bone metastases.
• Visual inter-individual comparison of lesion detection in 162 patients across various malignancies.
• Analysis of normal bone-to-soft tissue ratios.

Main Results:

• Quantitative analysis showed a statistically significant higher lesion-to-normal bone ratio for MDP (2.9 ± 1.6) compared to DPD (2.4 ± 1.2).
• No significant difference was observed in normal bone-to-soft tissue ratios between MDP and DPD.
• Visual analysis across 162 patients revealed no significant difference in detecting focal lesions between MDP and DPD preparations.

Conclusions:

• Both 99Tcm-MDP and 99Tcm-DPD are effective bone-seeking agents for detecting bone metastases.
• The observed quantitative difference between MDP and DPD is considered academic and lacks practical clinical significance.
• The choice between MDP and DPD for bone metastasis detection may not impact diagnostic outcomes.